BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3842935)

  • 21. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [SCC antigen: a sensitive and specific tumor marker for squamous cell carcinoma?].
    Fischbach W; Rink C
    Dtsch Med Wochenschr; 1988 Feb; 113(8):289-93. PubMed ID: 2449322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
    Clasen B; Roettger D; Senekowitsch R; Menz E
    Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
    Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of SCC-TA4 determination in 4 localizations of epidermoid cancers. An experience of the FNCLCC subgroup of radio-analysis].
    Daver A; Dalifard I; Pons-Anicet D; Krebs BP; Gosselin P; Cazin JL; Ricolleau G; Gaillard G; Gachon F; Goussard J
    Bull Cancer; 1990; 77(8):781-92. PubMed ID: 2207367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of serum beta 2-microglobulin in squamous cell carcinoma of the lung].
    Higuchi Y; Togawa T; Moriya H; Hoshi K; Satoh T; Kimura K
    Gan No Rinsho; 1986 Dec; 32(15):1919-24. PubMed ID: 3543434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An immunoradiometric assay of serum SCC antigen using a monoclonal antibody--a comparison with the conventional double antibody method].
    Mino N; Iio A; Ata M; Hamamoto K
    Gan No Rinsho; 1988 Mar; 34(3):321-5. PubMed ID: 3357252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fundamental and clinical evaluation of the SCC RIA kit].
    Habuchi Y; Hamasaki T; Handa F; Bito S; Jeong S; Yamaguchi H; Saiki Y; Ito H; Hino M; Ikekubo K
    Kaku Igaku; 1986 Jul; 23(7):967-72. PubMed ID: 3784126
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum squamous cell carcinoma-related antigen in lung cancer--a marker for the extent of the disease and response to therapy].
    Reshad K; Inui K; Takahashi Y; Itoi K; Nakano Y; Sakamoto M; Suzuki K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Aug; 24(8):878-83. PubMed ID: 3795641
    [No Abstract]   [Full Text] [Related]  

  • 34. [An expression of an SCC antigen in oral cancer].
    Tsuji T; Sasaki K; Matsumura K; Tanaka K; Kawasaki M; Nakashima K; Takahashi M; Shinozaki F
    Gan No Rinsho; 1987 Dec; 33(15):1875-8. PubMed ID: 3430739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyfra 21.1, TPS and SCC in squamous cell carcinoma of larynx.
    Monteiro E; Varzim G; Crespo M; Araújo L
    An Otorrinolaringol Ibero Am; 2003; 30(5):467-79. PubMed ID: 14648927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of squamous cell carcinoma (SCC)-related antigens in cutaneous SCC. A preliminary report.
    Yagi H; Danno K; Maruguchi Y; Yamamoto M; Imamura S
    Arch Dermatol; 1987 Jul; 123(7):902-6. PubMed ID: 3606169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer.
    Takeuchi S; Nonaka M; Kadokura M; Takaba T
    Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):98-104. PubMed ID: 12732086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
    Tsai SC; Kao CH; Wang SJ
    Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.